Patients with myelodysplastic syndromes (MDS) challenge transfusion resources now and in the future

被引:0
|
作者
Plesnila-Frank, C. [1 ]
Rottenkolber, D. [2 ]
Berger, K. [2 ]
机构
[1] Med Econ Res Grp, Munich, Germany
[2] Univ Hosp Munich, Munich, Germany
关键词
D O I
10.1016/S1098-3015(10)65041-3
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A283 / A284
页数:2
相关论文
共 50 条
  • [1] Patients with myelodysplastic syndromes (MDS) challenge transfusion resources now and in the future
    Plesnila-Frank, C.
    Berger, K.
    Vioni-Niemeyer, A.
    Schramm, W.
    LEUKEMIA RESEARCH, 2007, 31 : S112 - S112
  • [2] Transfusion independence (TI) in patients with myelodysplastic syndromes (MDS) treated with azacitidine (AZA)
    Silverman, L.
    Fenaux, P.
    Santini, V.
    Seymour, J.
    Mufti, G.
    Hellstrom-Lindberg, E.
    Giagounidis, A.
    Sanz, G.
    Bennett, J.
    Backstrom, J.
    McKenzie, D.
    Beach, C.
    LEUKEMIA RESEARCH, 2009, 33 : S133 - S134
  • [3] Pregnancy in patients with myelodysplastic syndromes (MDS)
    Volpicelli, P.
    Latagliata, R.
    Breccia, M.
    Carmosino, I.
    Stefanizzi, C.
    Iannella, E.
    Levi, A.
    Natalino, F.
    Alimena, G.
    LEUKEMIA RESEARCH, 2007, 31 : S107 - S107
  • [4] Pregnancy in patients with myelodysplastic syndromes (MDS)
    Volpicelli, P.
    Latagliata, R.
    Breccia, M.
    Carmosino, I.
    Stefanizzi, C.
    Napoleone, L.
    Vozella, F.
    Levi, A.
    Natalino, E.
    Alimena, G.
    LEUKEMIA RESEARCH, 2008, 32 (10) : 1605 - 1607
  • [5] Do ESAs Reduce Transfusion Need among Transfusion-Dependent Myelodysplastic Syndromes (MDS) Patients?
    Smith, Sheila R. Weiss
    Sato, Masayo
    Baer, Maria R.
    Ke, Xuehua
    Gore, Steven D.
    Davidoff, Amy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S282 - S283
  • [6] Cost of transfusion-dependent myelodysplastic syndromes (MDS) in Germany
    Kuehne, F.
    Mittendorf, T.
    Voelkl, M.
    Lipp, R.
    Germing, U.
    Vioni-Niemeyer, A.
    von der Schulenburg, J. M.
    LEUKEMIA RESEARCH, 2007, 31 : S111 - S111
  • [7] Cost of transfusion-dependent myelodysplastic syndromes (MDS) in Germany
    Kuehne, F. C.
    Mittendorf, T.
    Voelkl, M.
    Lipp, R.
    Germing, U.
    Vioni-Niemeyer, A.
    Von der Schulenburg, J. M.
    VALUE IN HEALTH, 2007, 10 (06) : A282 - A282
  • [8] Cost of transfusion-dependent myelodysplastic syndromes (MDS) in Germany
    Kuehne, C.
    Mittendorf, T.
    Voelk, M.
    Lipp, R.
    Gerning, U.
    Vionniemeyer, A.
    von der Schulenberg, J. M. Graf
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 547 - 547
  • [9] COST CHANGES ASSOCIATED WITH ACHIEVING TRANSFUSION INDEPENDENCE (TI) IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    DeZern, A. E.
    Binder, G.
    Rizvi, S.
    Corvino, F. A.
    Arikian, S. R.
    Surinach, A.
    Lee, J.
    Smith, B. D.
    HAEMATOLOGICA, 2016, 101 : 500 - 500
  • [10] Myelodysplastic syndromes (MDS)
    Reinhard Stauder
    memo - Magazine of European Medical Oncology, 2009, 2 (2) : 108 - 109